Thomas Noh, MD, of Hawaii Pacific Health, and Douglas Musser, DO, of Youngstown Orthopedics Associates, performed the procedures, according to a Nov. 8 news release.
The Lucent interbody system received FDA clearance in April. It is designed to allow surgeons to deliver a large amount of tightly packed graft inside the device for fusions. The device is made for a posterior approach and has straight and curved designs.
“We are thrilled to share this technology with the surgical community,” Spinal Elements CEO Jason Blain said in the release. “Lucent 3D’s novel design is meant to address subsidence and the amount of bone graft material available for fusion — two clinical challenges surgeons note exist with other 3D-printed interbody devices.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
